FDA Approved: * July 15, 2016
Pharm Company: * ANI PHARMS INC
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Nilutamide Overview

Nilutamide, sold under the brand names Nilandron and Anandron, is a nonsteroidal antiandrogen (NSAA) which is used in the treatment of prostate cancer.[7][8][9][10][11][12] It has also been studied as a component of feminizing hormone therapy for transgender women and to treat acne and seborrhea in women.[13][14][15][16] It is taken by...

Read more Nilutamide Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Nilutamide Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Tablet: 150mg, 50mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Nilutamide: (2 results)

Sorted by National Drug Code
  • 62559-173 Nilutamide 150 mg Oral Tablet by Ani Pharmaceuticals, Inc.
  • 66993-212 Nilutamide 150 mg Oral Tablet by Prasco Laboratories

Other drugs which contain Nilutamide or a similar ingredient: (1 result)

Related Nilutamide Topics:

Nilutamide Hygroscopicity
plz let me know the Hygroscopicity of Nilutamide...